Zacks Research cut shares of WuXi AppTec (OTCMKTS:WUXAY – Free Report) from a strong-buy rating to a hold rating in a research note released on Monday,Zacks reports.
WuXi AppTec Price Performance
Shares of OTCMKTS:WUXAY opened at $28.00 on Monday. WuXi AppTec has a 52 week low of $12.45 and a 52 week high of $28.69. The company’s 50 day moving average is $25.26 and its two-hundred day moving average is $19.96.
About WuXi AppTec
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
